ZHANG KER sold $634K of AMBQ
ZHANG KER sold 10,000 shares of Ambiq Micro, Inc. (AMBQ) at an average of $63.44 ($63.39–$63.95, $0.63M total) across 2 trades on 2026-09-11.
Ambiq Micro, Inc.
Reads like this one publish minutes after the filing lands on EDGAR. Get them as JSON over the API or inside your AI agent over MCP.
No enriched coverage for $AMBQ in the last 7 days.
ZHANG KER sold 10,000 shares of Ambiq Micro, Inc. (AMBQ) at an average of $63.44 ($63.39–$63.95, $0.63M total) across 2 trades on 2026-09-11.
Chen Sean Chihhsiang (President and COO) sold 15,000 shares of Ambiq Micro, Inc. (AMBQ) at an average of $60.14 ($59.36–$60.83, $0.90M total) across 3 trades on 2026-09-14 under a Rule 10b5-1 trading plan.
Esaka Fumihide (Chief Executive Officer) sold 63,500 shares of Ambiq Micro, Inc. (AMBQ) at an average of $62.70 ($59.56–$63.86, $3.98M total) across 5 trades over 2026-09-11 to 2026-09-15 under a Rule 10b5-1 trading plan.
Recent AMBQ coverage spans insider activity, financial news and earnings.
In the last 30 days, AMBQ insiders filed 27 SEC Form 4 transactions — no purchases and 27 sales ($14.6M). The most active reporter was Esaka Fumihide, Chief Executive Officer, with 14 filings. 81% of those filings were made under pre-arranged Rule 10b5-1 plans.
The insider sale modestly reduces insider ownership but is unlikely to move the stock price.
Insider sale may signal confidence level and could pressure the stock short term.
The insider sale may signal reduced confidence and could pressure the stock short-term.
Insider sale may signal confidence level but size is modest.
Small insider sale with modest proceeds; unlikely to move price materially.
AlphAI scores every news story that mentions AMBQ with an AI model for sentiment and relevance, and aggregates insider trades from Ambiq Micro, Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
ZHANG KER sold 10,000 shares of Ambiq Micro, Inc. (AMBQ) at an average of $63.44 ($63.39–$63.95, $0.63M total) across 2 trades on 2026-09-11.
1 min readChen Sean Chihhsiang (President and COO) sold 15,000 shares of Ambiq Micro, Inc. (AMBQ) at an average of $60.14 ($59.36–$60.83, $0.90M total) across 3 trades on 2026-09-14 under a Rule 10b5-1 trading plan.
1 min readEsaka Fumihide (Chief Executive Officer) sold 63,500 shares of Ambiq Micro, Inc. (AMBQ) at an average of $62.70 ($59.56–$63.86, $3.98M total) across 5 trades over 2026-09-11 to 2026-09-15 under a Rule 10b5-1 trading plan.
1 min readChen Sean Chihhsiang (President and COO) sold 15,000 shares of Ambiq Micro, Inc. (AMBQ) at an average of $57.17 ($57.09–$57.68, $0.86M total) across 2 trades on 2026-09-04 under a Rule 10b5-1 trading plan.
1 min readAmbiq Micro (AMBQ) director Ker Zhang exercised options for 1,785 shares at $5.88 each on September 4, 2026, and sold 185 shares at $56.92 per share. The option was fully exercised with no remaining balance. No Rule 10b5-1 trading plan was reported.
1 min readEsaka Fumihide (Chief Executive Officer) sold 108,500 shares of Ambiq Micro, Inc. (AMBQ) at an average of $56.89 ($56.15–$58.52, $6.17M total) across 9 trades over 2026-08-31 to 2026-09-02 under a Rule 10b5-1 trading plan.
1 min readAmbiq Micro's CTO and Director, Hanson Scott McLean, sold 55,000 shares at weighted average prices of $59.58 to $60.32, totaling $3.28M. He now directly owns 221,226 shares. The sales occurred in multiple transactions on August 26-27, 2026, according to SEC filings.
1 min readHanson Scott McLean (Chief Technology Officer) sold 55,000 shares of Ambiq Micro, Inc. (AMBQ) at an average of $59.69 ($59.58–$60.32, $3.28M total) across 3 trades over 2026-08-26 to 2026-08-27.
1 min readEsaka Fumihide (Chief Executive Officer) sold 13,500 shares of Ambiq Micro, Inc. (AMBQ) at an average of $64.39 ($63.29–$65.26, $0.87M total) across 3 trades on 2026-08-14 under a Rule 10b5-1 trading plan.
2 min readAmbiq Micro (NYSE:AMBQ) reported second-quarter results with revenue of $34m, 7.6% above analyst forecasts, and statutory losses of $0.32 per share, 7.6% smaller than expected. Analysts’ 2026 consensus calls for revenue of $135.1m (up from $122.5m) and losses around $1.50 per share, with the price target unchanged at $85.67.
4 min read